Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Apr;53(7):2100-2116.
doi: 10.1111/ejn.14742. Epub 2020 May 2.

What's wrong with the striatal cholinergic interneurons in Parkinson's disease? Focus on intrinsic excitability

Cecilia Tubert  1 , Mario Gustavo Murer  1
Affiliations
Review

What's wrong with the striatal cholinergic interneurons in Parkinson's disease? Focus on intrinsic excitability

Cecilia Tubert et al. Eur J Neurosci. 2021 Apr.

Abstract

Parkinson's disease (PD) is characterized by a degeneration of nigrostriatal dopaminergic neurons that results in a hypercholinergic state in the striatum. This hypercholinergic state contributes to the clinical signs of PD. However, the mechanisms that underlie this state remain unknown. Cholinergic interneurons (ChIs) are the main source of acetylcholine in the striatum. Many studies have highlighted the importance of their normal physiological activity to guarantee a normal motor control and goal-directed behaviour. Moreover, recent studies with optogenetic and chemogenetic approaches have shown that reducing ChIs activity ameliorates parkinsonian symptoms and modifies L-dopa induced dyskinesia in PD animal models. Here, we review the described alterations in ChIs physiology that may contribute to a hypercholinergic state in PD. The best-established finding is an increase of ChIs intrinsic membrane excitability after dopaminergic denervation of striatum. Understanding the molecular basis of ChIs dysfunction in PD could help to develop new therapeutic tools to restore their normal activity and decrease parkinsonian symptoms, improving life quality of PD patients.

Keywords: Parkinson´s disease; cholinergic interneurons; hypercholinergic state; hyperexcitability; pause response; potassium channels.

PubMed Disclaimer

References

REFERENCES

    1. Abudukeyoumu, N., Hernandez-Flores, T., Garcia-Munoz, M., & Arbuthnott, G. W. (2019). Cholinergic modulation of striatal microcircuits. European Journal of Neuroscience, 49(5), 604-622. https://doi.org/10.1111/ejn.13949
    1. Ahmed, N. Y., Knowles, R., & Dehorter, N. (2019). New insights into cholinergic neuron diversity. Frontiers in Molecular Neuroscience, 12, 204. https://doi.org/10.3389/fnmol.2019.00204
    1. Alcantara, A. A., Chen, V., Herring, B. E., Mendenhall, J. M., & Berlanga, M. L. (2003). Localization of dopamine D2 receptors on cholinergic interneurons of the dorsal striatum and nucleus accumbens of the rat. Brain Research, 986(1-2), 22-29. https://doi.org/10.1016/S0006-8993(03)03165-2
    1. Alcantara, A. A., Mrzljak, L., Jakab, R. L., Levey, A. I., Hersch, S. M., & Goldman-Rakic, P. S. (2001). Muscarinic m1 and m2 receptor proteins in local circuit and projection neurons of the primate striatum: Anatomical evidence for cholinergic modulation of glutamatergic prefronto-striatal pathways. Journal of Comparative Neurology, 434(4), 445-460. https://doi.org/10.1002/cne.1186
    1. Aldrin-Kirk, P., Heuer, A., Ottosson, D. R., Davidsson, M., Mattsson, B., & Björklund, T. (2018). Chemogenetic modulation of cholinergic interneurons reveals their regulating role on the direct and indirect output pathways from the striatum. Neurobiology of Disease, 109, 148-162. https://doi.org/10.1016/j.nbd.2017.10.010

Publication types

Substances

LinkOut - more resources